Sarepta Therapeutics
SRPT
#1592
Rank
โ‚น920.96 B
Marketcap
โ‚น9,642
Share price
3.38%
Change (1 day)
37.76%
Change (1 year)
Sarepta Therapeutics is an American medical research company dedicated to the discovery and development of precisely effective gene therapeutics for the treatment of rare neuromuscular diseases.

Sarepta Therapeutics (SRPT) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : โ‚น200.78 Billion

According to Sarepta Therapeutics 's latest financial reports the company's total liabilities are โ‚น200.78 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Sarepta Therapeutics - Total liabilities on balance sheet (from 2001 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31โ‚น200.23 B-11.8%
2022-12-31โ‚น227.01 B37.39%
2021-12-31โ‚น165.23 B1.64%
2020-12-31โ‚น162.57 B126.93%
2019-12-31โ‚น71.64 B68.02%
2018-12-31โ‚น42.63 B28.73%
2017-12-31โ‚น33.12 B457.6%
2016-12-31โ‚น5.94 B7.13%
2015-12-31โ‚น5.54 B84.65%
2014-12-31โ‚น3.00 B9.53%
2013-12-31โ‚น2.74 B-38.42%
2012-12-31โ‚น4.45 B260.42%
2011-12-31โ‚น1.23 B-43.5%
2010-12-31โ‚น2.18 B29.46%
2009-12-31โ‚น1.68 B258.39%
2008-12-31โ‚น0.47 B-2.03%
2007-12-31โ‚น0.48 B244.67%
2006-12-31โ‚น0.13 B12.85%
2005-12-31โ‚น0.12 B26.93%
2004-12-31โ‚น97.42 M-42.95%
2003-12-31โ‚น0.17 B-30.47%
2002-12-31โ‚น0.24 B55.15%
2001-12-31โ‚น0.15 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
โ‚น2.986 T 1,387.35%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น189.94 B-5.40%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น10.66 B-94.69%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น81.01 B-59.65%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น352.19 B 75.41%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น244.48 B 21.76%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น132.47 B-34.02%๐Ÿ‡บ๐Ÿ‡ธ USA